SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is generating significant market buzz ahead of its quarterly earnings release as investors weigh the company's aggressive pivot toward the data center CPU market against its high valuation. The community remains sharply divided, with bulls pointing to robust demand for AI-driven compute as a long-term catalyst, while bears argue that supply chain constraints and the recent vertical price rally suggest a bubble-like environment susceptible to a post-earnings selloff.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending as investors weigh strong Q1 earnings results, including improved free cash flow and user growth, against cautious guidance and the termination of a partnership. The community is actively debating the effectiveness of leadership and debating the potential for a long-term turnaround driven by cost-cutting initiatives and future hardware developments.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is gaining market attention as shareholders of Warner Bros. Discovery prepare for an upcoming pivotal vote on their proposed $110 billion merger. Community sentiment remains split, with some traders optimistic about the consolidation's long-term synergy potential while others voice frustration over price volatility and the broader implications of the deal's structure.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN Limited is trending as the community closely monitors its recent $625 million acquisition of Mirantis and anticipates upcoming earnings, fueling debates over the company's shift toward a full-stack AI cloud model. Investors are actively discussing the potential for major hyperscaler contract announcements and whether this move effectively bridges the gap in their AI software capabilities.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing strong momentum as investors weigh a potential buyout against the company's scaling revenue and upcoming clinical catalysts. The community is actively discussing the strong adoption of BRIUMVI and anticipation surrounding the subcutaneous formulation trial results, which many view as a critical inflection point for the stock.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc. is trending as investors react to a significant milestone where the company surpassed 200,000 policies through its partnership with Carvana, triggering the exercisability of warrants. Community discussion remains heavily polarized between bulls betting on rapid partnership-led growth and share buybacks, and bears highlighting persistent management insider selling, executive compensation concerns, and questions regarding the long-term sustainability of the current growth model.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending following an earnings beat that exceeded profit expectations and reaffirmed revenue guidance, sparking significant buying interest from the community. Investors are closely tracking the company's path to profitability and margin expansion, with many debating whether the current momentum marks the start of a sustained reversal.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is currently in focus as investors analyze the stock's sharp volatility following a contentious short-seller report and the company's subsequent rebuttal. The community is actively debating the stock's fundamental valuation, with many traders weighing the impact of share repurchases, recent regulatory developments, and potential earnings performance against the backdrop of competitive headwinds.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing increased bullish sentiment and volume, driven by excitement over its QNX software's expanding role in robotics and Physical AI partnerships. The community is actively tracking the stock's pivot toward software-driven growth and is closely monitoring potential institutional accumulation.

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Ernexa Therapeutics is seeing significant volatility following the release of preclinical data showing complete tumor clearance in ovarian cancer models, with the community polarized between optimism over the clinical potential and skepticism regarding historical share structure changes like reverse splits. Traders are heavily focused on the stock's low float and high short interest, fueling intense debate over whether the recent price action represents a legitimate breakthrough or a setup for further dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vanguard Group Inc. Sells 165,105 Shares of Western Alliance Bancorporation $WAL

Vanguard Group Inc. lowered its stake in shares of Western Alliance Bancorporation (NYSE:WAL - Free Report) by 1.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 10,335,676 shares of the financial services provider's stock after selling 165,105 shares duri...

Western Alliance Bancorporation Plans Quarterly Dividend of $0.42 (NYSE:WAL)

Western Alliance Bancorporation (NYSE:WAL) declared a quarterly dividend on Thursday, April 30th. Investors of record on Thursday, May 14th will be given a dividend of 0.42 per share by the financial...

Western Alliance Bancorporation (NYSE:WAL) Short Interest Down 24.7% in April

Western Alliance Bancorporation (NYSE:WAL - Get Free Report) was the recipient of a large decline in short interest during the month of April. As of April 15th, there was short interest totaling 2,251,017 shares, a decline of 24.7% from the March 31st total of 2,989,036 shares. Based on an average...

Western Alliance Bancorporation (NYSE:WAL) Given New $96.00 Price Target at Citigroup

Citigroup dropped their price target on shares of Western Alliance Bancorporation from $103.00 to $96.00 and set a "buy" rating for the company in a research report on Tuesday...

Keefe, Bruyette & Woods Boosts Western Alliance Bancorporation (NYSE:WAL) Price Target to $94.00

Keefe, Bruyette & Woods boosted their price objective on Western Alliance Bancorporation from $93.00 to $94.00 and gave the stock an "outperform" rating in a research report on Thursday...

M&T Bank Corp Raises Stake in Western Alliance Bancorporation $WAL

M&T Bank Corp grew its stake in shares of Western Alliance Bancorporation (NYSE:WAL - Free Report) by 7,920.9% in the fourth quarter, according to its most recent disclosure with the Securities and...

Ruffer LLP Purchases Shares of 33,236 Western Alliance Bancorporation $WAL

Ruffer LLP purchased a new stake in shares of Western Alliance Bancorporation (NYSE:WAL - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and...

Western Alliance Bancorporation (NYSE:WAL) Given Consensus Rating of "Moderate Buy" by Analysts

Western Alliance Bancorporation (NYSE:WAL - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the fourteen research firms that are currently covering the stock...

DA Davidson Reaffirms "Buy" Rating for Western Alliance Bancorporation (NYSE:WAL)

DA Davidson reiterated a "buy" rating and issued a $93.00 price objective on shares of Western Alliance Bancorporation in a research note on Wednesday...

Western Alliance Bancorporation Reports Fall In Q1 Income

(RTTNews) - Western Alliance Bancorporation (WAL) reported earnings for first quarter that Drops, from last year...

Western Alliance Bancorp is a bank holding company, which engages in the provision of deposit, lending, treasury management, international banking, and online banking products and services. It operates through the following business segments: Commercial, Consumer Related, and Corporate and Other. The Commercial segment focuses on delivering commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. The Consumer Related segment provides commercial banking services to enterprises in consumer-related sectors and consumer banking services. The Corporate and Other segment represents the company's investment portfolio, corporate borrowings and other related items, income and expense items. The company was founded in 1995 and is headquartered in Phoenix, AZ.

Western Alliance Bancorp

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

WAL
Western Alliance Bancorp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest WAL News

WALWestern Alliance Bancorp